New York State Teachers Retirement System (NYSTRS)’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.68M | Buy |
44,077
+230
| +0.5% | +$24.4K | 0.01% | 814 |
|
2025
Q1 | $5.44M | Hold |
43,847
| – | – | 0.01% | 738 |
|
2024
Q4 | $5.4M | Buy |
43,847
+529
| +1% | +$65.1K | 0.01% | 779 |
|
2024
Q3 | $4.83M | Sell |
43,318
-391
| -0.9% | -$43.6K | 0.01% | 835 |
|
2024
Q2 | $4.67M | Buy |
43,709
+6,778
| +18% | +$723K | 0.01% | 814 |
|
2024
Q1 | $4.45M | Buy |
36,931
+4,700
| +15% | +$566K | 0.01% | 860 |
|
2023
Q4 | $3.96M | Hold |
32,231
| – | – | 0.01% | 908 |
|
2023
Q3 | $4.17M | Sell |
32,231
-400
| -1% | -$51.8K | 0.01% | 835 |
|
2023
Q2 | $4.05M | Hold |
32,631
| – | – | 0.01% | 862 |
|
2023
Q1 | $4.78M | Hold |
32,631
| – | – | 0.01% | 792 |
|
2022
Q4 | $5.2M | Buy |
32,631
+700
| +2% | +$112K | 0.01% | 760 |
|
2022
Q3 | $4.26M | Hold |
31,931
| – | – | 0.01% | 801 |
|
2022
Q2 | $4.98M | Buy |
31,931
+1,647
| +5% | +$257K | 0.01% | 767 |
|
2022
Q1 | $4.71M | Sell |
30,284
-300
| -1% | -$46.7K | 0.01% | 838 |
|
2021
Q4 | $3.9M | Buy |
30,584
+4,063
| +15% | +$518K | 0.01% | 937 |
|
2021
Q3 | $3.45M | Sell |
26,521
-3,980
| -13% | -$518K | 0.01% | 974 |
|
2021
Q2 | $5.42M | Buy |
30,501
+848
| +3% | +$151K | 0.01% | 780 |
|
2021
Q1 | $4.87M | Buy |
29,653
+3,753
| +14% | +$617K | 0.01% | 834 |
|
2020
Q4 | $4.28M | Buy |
25,900
+6,100
| +31% | +$1.01M | 0.01% | 846 |
|
2020
Q3 | $2.82M | Buy |
+19,800
| New | +$2.82M | 0.01% | 916 |
|
2020
Q1 | – | Sell |
-4,613
| Closed | -$689K | – | 1648 |
|
2019
Q4 | $689K | Buy |
+4,613
| New | +$689K | ﹤0.01% | 1346 |
|
2016
Q2 | – | Sell |
-5,200
| Closed | -$679K | – | 1664 |
|
2016
Q1 | $679K | Hold |
5,200
| – | – | ﹤0.01% | 1354 |
|
2015
Q4 | $731K | Sell |
5,200
-100
| -2% | -$14.1K | ﹤0.01% | 1350 |
|
2015
Q3 | $704K | Buy |
5,300
+3,300
| +165% | +$438K | ﹤0.01% | 1354 |
|
2015
Q2 | $352K | Buy |
+2,000
| New | +$352K | ﹤0.01% | 1462 |
|